Natera, Inc. (NAS: NTRA) Stock Analysis & Fundamentals | ScreenerHero

Create free account

NTRANatera, Inc.

NAS · US · Healthcare · Diagnostics & Research · natera.com

269.95USD-4.22%Mkt Cap: 38.66B $P/E: —Today

Natera, Inc., a diagnostics company, engages in the development and commercialization of molecular testing services worldwide. It offers Signatera, a personalized ctDNA blood test for MRD assessment, early recurrence mon…

Industry Peers

Diagnostics & Research

Thermo Fisher Scientific Inc.

$195.86BUSDP/E 28.9

Danaher Corporation

$140.88BUSDP/E 38.7

$46.71BUSDP/E 45.1

IDEXX Laboratories, Inc.

$44.46BUSDP/E 41.5

Agilent Technologies, Inc.

$37.93BUSDP/E 27.0

Waters Corporation

$36.96BUSDP/E 48.0

IQVIA Holdings Inc.

$34.69BUSDP/E 25.8

$28.78BUSDP/E 34.6

Mettler-Toledo International Inc.

$26.19BUSDP/E 30.4

Quest Diagnostics Incorporated

$22.96BUSDP/E 22.9

Labcorp Holdings Inc.

$22.70BUSDP/E 24.5

Guardant Health, Inc.

Medpace Holdings, Inc.

$15.37BUSDP/E 33.9

Eurofins Scientific SE

$12.97BUSDP/E 27.0

$12.53BUSDP/E 54.0

Charles River Laboratories International, Inc.

bioMérieux S.A.

$9.01BUSDP/E 21.0

BillionToOne, Inc.

$5.83BUSDP/E 234.8

Twist Bioscience Corporation

Sotera Health Company

$5.25BUSDP/E 44.9

$4.55BUSDP/E 52.8

DiaSorin S.p.A.

$3.70BUSDP/E 26.1

Adaptive Biotechnologies Corporation

GeneDx Holdings Corp.

NeoGenomics, Inc.

Vimian Group AB (publ)

$1.54BUSDP/E 39.0

Diagnostyka S.A.

$1.55BUSDP/E 23.5

Personalis, Inc.

Clínica Baviera, S.A.

$1.01BUSDP/E 21.1

OPKO Health, Inc.

Castle Biosciences, Inc.

$655.97MUSDP/E 42.7

Fulgent Genetics, Inc.

Myriad Genetics, Inc.

$297.91MUSDP/E 3.0

Spectral Medical Inc.

Insight Molecular Diagnostics Inc.

Scope Fluidics S.A.

Eurofins-Cerep SA

$89.37MUSDP/E 17.2

Pangaea Oncology, S.A.

Abingdon Health Plc

Immunovia AB (publ)

ENDRA Life Sciences Inc.

Proteome Sciences plc

Avricore Health Inc.

Oxford BioDynamics Plc

bioAffinity Technologies, Inc.

Leveljump Healthcare Corp.

$3.86MUSDP/E 2.8

Telo Genomics Corp.

Prostatype Genomics AB (publ)

ProPhase Labs, Inc.

Many Bright Ideas Technologies Inc.

$314.2KUSDP/E Infinity

T2 Biosystems, Inc.

Indicators:|

Key Statistics

Company

Market Cap38.66B $

Enterprise Value39.52B $

Revenue (TTM)2.50B $

Gross Profit1.49B $

Net Income (TTM)-208.16M $

Revenue/Share18.07 USD

Last Price269.95 USD

Fiscal Year EndDec 2025

MR QuarterMar 2026

Employees6.1K

CountryUS

SectorHealthcare

IndustryDiagnostics & Research

ISIN—

Valuation

P/E (Trailing)—

P/E (Forward)-1321.63

PEG—

EV/EBITDA-147.69

EV/Revenue15.80

P/S16.14

P/B22.68

EPS (TTM)-1.66

EPS (Forward)-0.21

52W Range

131.8188% of range288.04

52W High288.04 USD

52W Low131.81 USD

Profitability

Gross Margin64.75%

Oper. Margin-12.39%

EBITDA Margin-10.70%

Profit Margin-9.03%

ROE-12.16%

ROA-8.68%

Growth

Revenue Growth38.80%

Earnings Growth—

Cash Flow & Leverage

Operating CF215.30M $

CapEx (TTM)139.19M $

FCF Margin5.47%

FCF Yield0.35%

Net Debt-847.85M $

Net Debt/EBITDA3.17

Balance Sheet

Debt/Equity0.13

Current Ratio2.96

Quick Ratio2.70

Book Value/Sh12.43 USD

Cash/Share7.596 USD

Dividends

Fwd Div Rate—

Trail. Div Rate0.0000 USD

Div. Yield—

5Y Avg Yield—

Payout Ratio0.00%

Ex-Div Date—

Pay Date—

Analyst Consensus

Rating1.5 (Buy)

Strong BuyBuyHoldSellStr. Sell

Target (Mean)266.00 USD

Upside (mean)-1.5%

Target Range193.00 USD – 310.00 USD

$193.00-1.5% to mean$310.00

# Analysts21

Ownership

Shares Out.143.22M

Float139.06M

Insiders2.98%

Institutions95.97%

Short Interest

Short Ratio3.1d

Short % Float3.11%

Short % Out.3.01%

Shares Short4.32M

Short (prev mo.)3.78M

Technical

SMA 50222.57 (+21.3%)

SMA 200212.20 (+27.2%)

Beta1.50

S&P 52W Chg20.11%

Avg Vol (30d)1.41M

Avg Vol (10d)1.96M

Technical Indicators

RSI (14)65.0

MACD17.4941

MACD Signal15.8549

MACD Hist.+1.6392

BB Upper303.51 USD

BB Middle250.26 USD

BB Lower197.00 USD

BB Width42.56%

ATR (14)12.14 USD

Vol Ratio (20d)0.60x